Neoadjuvant Cadonilimab Plus Chemotherapy Following Short-Course Radiotherapy in Locally Advanced Rectal Cancer

NCT05792735 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Rectal Carcinoma

Interventions

DRUG: Cadonilimab Injection
RADIATION: Short-course radiotherapy
DRUG: Consolidation chemotherapy

Sponsor

Shenzhen People's Hospital

Collaborators

[object Object]
[object Object]